The firm upgraded the pharmaceutical stock to buy from hold.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.
Veytics Intelligence
Mounjaro's maker has more room to run amid GLP-1 boom, Berenberg says
